ATM and cancer: Thus, with OS seemingly poor in multiple cancer types with ATM alterations regardless of immunotherapy or platinum‐based treatment,9 one could assume that patients with tumors harboring ATM alterations would need a novel therapeutic approach for improving outcomes.